Skip to content
Blood Test Tracker

CK-MB

A heart-muscle form of the enzyme creatine kinase. It was long used to look for heart muscle injury, and troponin has now mostly replaced it.

AI-drafted. Awaiting verificationAlso called CK-MB, CKMB, CPK-MBLOINC 13969-1

Check your result

Sex (optional)

Type your result to see where it falls.

Nothing you type here leaves your browser.

What it is

Creatine kinase (CK) is an enzyme found in muscle. It comes in three forms, and CK-MB is the form found mostly in heart muscle, with smaller amounts in other muscle. When heart muscle cells are injured, CK-MB leaks into the blood. Modern labs measure how much CK-MB there is (its mass), and the result is usually in ng/mL.

Why it matters

For years, CK-MB was the standard blood test for a heart attack. Today, cardiac troponin has replaced it in most places because troponin is more specific to the heart and more sensitive to small injuries. A 2026 international consensus says to use CK-MB, measured as a mass test, only when troponin isn't available. You may still see it on older panels or in reports from some hospitals.

If it’s high

A higher result means more CK-MB in your blood, which is a sign that muscle cells, most often heart muscle, have been injured. The number can't say what caused the injury, and a small rise has many possible causes. Your clinician reads it alongside your symptoms, an ECG and a troponin test.

Common causes

  • Hard or long exercise, or injury to skeletal muscle, which can raise CK-MB without any heart damage
  • Recent surgery, intramuscular injections or cardiac catheterization
  • Heart muscle injury, including a heart attack
  • Inflammation of the heart muscle (myocarditis), often caused by a virus
  • Open-heart surgery, a heart shock (defibrillation), an electrical injury or a heart injury such as a car accident
  • Heart failure or a blood clot in the lung
  • An underactive thyroid or kidney failure

What can help

  • Tell your clinician about recent hard exercise, injections, surgery or heart procedures
  • Ask whether a troponin test or a repeat CK-MB would help put the result in context

Usual ranges

What labs print as the reference range, by who was tested. Ranges differ a little between labs, so the range on your own report is the one your result is judged against.

For adults: 0–5 ng/mL. Source: Practical Laboratory Medicine, Cureus.

What can affect your result

  • Method: mass (ng/mL or µg/L), activity (U/L) and electrophoresis (percent of total CK) are different measurements
  • Sex: in a 2025 healthy-adult study of a different assay, upper limits were higher in men than in women
  • Timing: levels rise within hours of heart muscle injury and fall back over a few days
  • Hard or long exercise, muscle injury, injections, recent surgery and cardiac catheterization
  • Other conditions, such as heart failure, a blood clot in the lung, an underactive thyroid and kidney failure
  • Hard or long exercise, muscle injury, intramuscular injections, recent surgery and cardiac catheterization can all change CK and CK-MB results without a new heart problem (MedlinePlus).
  • CK-MB can be measured three ways, as a mass (ng/mL or µg/L), as enzyme activity (U/L) and as a percent of total CK by electrophoresis. They are different measurements and can't be converted, so compare a result only with the same method.
  • Each assay maker sets its own upper limit, so ranges differ between labs and platforms.

Rises about 3 to 6 hours after heart muscle injury, peaks at roughly 12 to 24 hours, and settles back within about 1 to 4 days (sources differ). It does not reflect long-term change.

When to talk to a clinician

Chest pain or pressure, trouble breathing, pain that spreads to the arm, jaw or back, a cold sweat, nausea or fainting can be signs of a heart problem. If you have these, call 911 or your local emergency number, whatever your lab results say. If a CK-MB result is outside your lab's range and no one has contacted you, call the clinician who ordered the test.

Questions you could ask

  • Why was CK-MB ordered, and is troponin also being checked?
  • Which range on my report applies to this assay?
  • Could exercise, an injection, a procedure or another condition explain this result?
  • Do we need a troponin test or a repeat CK-MB to put this in context?
  • Should we look at anything else, such as my ECG, thyroid or kidney function?

Questions people ask

Why did my clinician order troponin instead of CK-MB?

Troponin is more sensitive and more specific for heart muscle injury than CK-MB. A 2026 international consensus says to use CK-MB, measured as a mass test, only if troponin isn't available. You may still see CK-MB on older panels.

My CK-MB is a little high. Does that mean a heart attack?

Not by itself. Hard exercise, muscle injury, injections, recent surgery and several conditions outside the heart can raise CK-MB. A clinician looks at your symptoms, an ECG and a troponin test along with it.

My report shows CK-MB in U/L or as a percent. Is that the same test?

No. The usual mass test reports ng/mL, which is the same as µg/L. Older activity tests report U/L, and electrophoresis reports CK-MB as a percent of total CK. They measure different things and can't be converted, so compare each only with the range on your own report.

Show the science and sources

Units

  • 1 ng/mL = 1 ng/mL
  • 1 ng/mL = 1 µg/L

Is a change real?

CK-MB naturally varies about 18.4% from test to test in the same healthy person. Between two results from the same lab, a rise of 76% or more, or a fall of 43% or more, is unlikely to be day-to-day noise or lab variation (95% reference change value). Source: Desirable Biological Variation Database specifications, 2014 update (Minchinela J, Ricos C, et al.; the 'Ricos database', a compilation of median published CVI/CVG).

For clinicians and researchers

CK-MB (CK-2) is the hybrid isoenzyme of creatine kinase made of one M and one B subunit. Heart muscle holds relatively more of it than skeletal muscle, but skeletal muscle injury can still raise it, so it is less cardiac-specific than troponin. The mass assay is a two-site immunoassay reported in ng/mL (equal to µg/L). Older activity assays (U/L) and electrophoretic assays (percent of total CK, for example Labcorp's 0 to 3%) are different measures and are not convertible. After myocardial injury it rises at about 3 to 6 hours, peaks near 12 to 24 hours and normalizes in roughly 1 to 4 days (MedlinePlus: 12 to 48 hours after tissue death; a 2024 table: 72 to 96 hours; a 2025 study: elevated for 2 to 3 days), which is why it was once used to date recent injury and spot a second infarction. The 2026 Fifth Universal Definition of Myocardial Infarction (ESC/ACC/AHA/WHF) prefers cardiac troponin. If no high-sensitivity troponin is available, a conventional troponin assay is preferred over CK-MB, which has lower sensitivity and specificity, and CK-MB measured by mass is an alternative only when no troponin assay is available. It also says CK-MB adds cost without diagnostic clarity for a suspected recurrent infarction. Upper reference limits are assay-specific and sex-specific. A 2025 evaluation of a different immunoassay reported upper limits from 262 healthy adults of about 3.9 ng/mL overall, about 4.5 to 5.1 ng/mL in men and about 2.4 to 2.7 ng/mL in women, so sex-specific limits are plausible. The Siemens Atellica IM CK-MB decision threshold is 5 ng/mL.

LOINC 13969-1 (primary), 83092-7. Specimen: serum-or-plasma.

Sources

  1. Fifth Universal Definition of Myocardial Infarction (2026), Global Heart (ESC/ACC/AHA/WHF Task Force) (2026)
  2. Preliminary comparative evaluation of an immunofluorescence point-of-care system and central laboratory platforms for measuring cardiac biomarkers, Practical Laboratory Medicine (2026)
  3. Evaluation of the Analytical Performance of a High-Precision Immunoassay for the Creatine Kinase-MB Isoenzyme, Cureus (2025)
  4. CPK isoenzymes test, MedlinePlus (National Library of Medicine) (2025)
  5. Creatine Kinase: MedlinePlus Medical Test, MedlinePlus (National Library of Medicine)
  6. Cardiac biomarkers in athletes and active individuals: a clinical review of exercise-induced elevations and diagnostic interpretation, Frontiers in Physiology (2026)
  7. Importance of H-FABP in Early Diagnosis of Acute Myocardial Infarction, International Journal of General Medicine (2024)
  8. Dynamic profiles of 25 serum biomarkers in acute myocardial infarction, Frontiers in Cardiovascular Medicine (2025)
  9. CK, Total+Isoenzymes, Serum, sample patient report (test 002154), Labcorp (2020)
  10. LOINC 13969-1 Creatine kinase.MB [Mass/volume] in Serum or Plasma, Regenstrief Institute (LOINC)

AI-drafted. Awaiting verification. Last reviewed 2026-10-03. How we build and check these pages.

Related markers